Conference Coverage

Protocol helped identify hospitalized children at risk for VTE


 

REPORTING FROM THSNA 2018


The researchers also found that upon initial admission, 7.9% of VTE cases were identified as high risk and another 21.9% were identified as moderate risk, compared with 1.2% and 3.7% in the controls, respectively.

“Patients identified as moderate or high risk for VTE were generally more medically complex patients,” Dr. Southard said.


Future directions of this project include expanding the patient population that has a risk assessment performed.

Dr. Southard reported having no financial disclosures.

SOURCE: Southard E et al. THSNA 2018.

Pages

Recommended Reading

VIDEO: Cystic fibrosis patients need earlier, more frequent colorectal cancer screening
MDedge Hematology and Oncology
Preoperative exercise lowers postoperative lung resection complications
MDedge Hematology and Oncology
The T-cell repertoire in NSCLC: Therapeutic implications
MDedge Hematology and Oncology
Imfinzi approved for stage III unresectable NSCLC
MDedge Hematology and Oncology
MDedge Daily News: Could gut bacteria trigger autoimmune diseases?
MDedge Hematology and Oncology
FDA wants data on role of flavored tobacco products in youth initiation
MDedge Hematology and Oncology
MDedge Daily News: Stem cells may reverse premature menopause
MDedge Hematology and Oncology
Xenon imaging could detect lung involvement after HSCT
MDedge Hematology and Oncology
Many VTE patients live in fear of the next event
MDedge Hematology and Oncology
MDedge Daily News: Why low-calorie sucralose may fuel weight gain
MDedge Hematology and Oncology